Form 8-K - Current report:
SEC Accession No. 0001654954-24-013720
Filing Date
2024-11-05
Accepted
2024-11-05 08:00:36
Documents
16
Period of Report
2024-11-04
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K endra_8k.htm   iXBRL 8-K 26505
2 CERTIFICATE OF AMENDMENT endra_ex31.htm EX-3.1 6293
  Complete submission text file 0001654954-24-013720.txt   161945

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA endra-20241104.xsd EX-101.SCH 5728
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE endra-20241104_lab.xml EX-101.LAB 15214
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE endra-20241104_cal.xml EX-101.CAL 901
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE endra-20241104_pre.xml EX-101.PRE 9643
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE endra-20241104_def.xml EX-101.DEF 2102
18 EXTRACTED XBRL INSTANCE DOCUMENT endra_8k_htm.xml XML 4030
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 241425705
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)